RT Journal Article
SR Electronic
T1 Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.07.20093542
DO 10.1101/2020.05.07.20093542
A1 Matthew A. Lalli
A1 S. Joshua Langmade
A1 Xuhua Chen
A1 Catrina C. Fronick
A1 Christopher S. Sawyer
A1 Lauren C. Burcea
A1 Michael N. Wilkinson
A1 Robert S. Fulton
A1 Michael Heinz
A1 William J. Buchser
A1 Richard D. Head
A1 Robi D. Mitra
A1 Jeffrey Milbrandt
YR 2020
UL http://medrxiv.org/content/early/2020/08/06/2020.05.07.20093542.abstract
AB Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19 pandemic. Current gold standard nucleic acid tests are hampered by supply shortages in critical reagents including nasal swabs, RNA extraction kits, personal protective equipment (PPE), instrumentation, and labor. Here we present an approach to overcome these challenges with the development of a rapid colorimetric assay using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) optimized on human saliva samples without an RNA purification step. We describe our optimizations of the LAMP reaction and saliva pretreatment protocols that enabled rapid and sensitive detection of < 102 viral genomes per reaction in contrived saliva controls. Moreover, our saliva pretreatment protocol enabled sensitive viral detection by conventional quantitative reverse transcription polymerase chain reaction (qRT-PCR) without RNA extraction. We validated the high performance of these assays on clinical samples and demonstrate a promising approach to overcome the current bottlenecks limiting widespread testing.Competing Interest StatementWashington University in St. Louis has filed patent applications regarding this technology on behalf of the inventors.Funding StatementThese studies were supported by donations to the WUSM COVID Research fund, the Department of Genetics and the McDonnell Genome Institute, and NIH grants P30 CA91842 and UL1 TR000448.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Saliva collection was approved by the institutional review board at Washington University School of Medicine (WU350, IRB#202003085). Informed consent was obtained for all participant samplesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are contained within the paper.